Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ludes-Meyers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Molecular Histology|August 31, 2006
WWOX protein expression in normal human tissuesMaria I Nunez, John Ludes-Meyers, C Marcelo Aldaz
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 7, 2016
Molecular Modeling, de novo Design and Synthesis of a Novel, Extracellular Binding Fibroblast Growth Factor Receptor 2 Inhibitor Alofanib (RPT835)Ilya Tsimafeyeu, Frits Daeyaert, Jean-Baptiste Joos, et al.
Breast Cancer Research and Treatment|February 5, 2005
Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor statusMaría I Nunez, John Ludes-Meyers, Martín C Abba, et al.
Oncogene|October 26, 2002
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthYongmin Liu, John Ludes-Meyers, Yun Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2016
Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour modelsIlya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2016
Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20-28]Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, et al.
Nature Protocols|October 6, 2021
Expression and characterization of SARS-CoV-2 spike proteinsJeffrey M Schaub, Chia-Wei Chou, Hung-Che Kuo, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structure-based Design of Prefusion-stabilized SARS-CoV-2 SpikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Science (New York, N.Y.)|July 25, 2020
Structure-based design of prefusion-stabilized SARS-CoV-2 spikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Molecular Histology|August 31, 2006
WWOX protein expression in normal human tissuesMaria I Nunez, John Ludes-Meyers, C Marcelo Aldaz
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 7, 2016
Molecular Modeling, de novo Design and Synthesis of a Novel, Extracellular Binding Fibroblast Growth Factor Receptor 2 Inhibitor Alofanib (RPT835)Ilya Tsimafeyeu, Frits Daeyaert, Jean-Baptiste Joos, et al.
Breast Cancer Research and Treatment|February 5, 2005
Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor statusMaría I Nunez, John Ludes-Meyers, Martín C Abba, et al.
Oncogene|October 26, 2002
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthYongmin Liu, John Ludes-Meyers, Yun Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2016
Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour modelsIlya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2016
Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20-28]Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, et al.
Nature Protocols|October 6, 2021
Expression and characterization of SARS-CoV-2 spike proteinsJeffrey M Schaub, Chia-Wei Chou, Hung-Che Kuo, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structure-based Design of Prefusion-stabilized SARS-CoV-2 SpikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Science (New York, N.Y.)|July 25, 2020
Structure-based design of prefusion-stabilized SARS-CoV-2 spikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Pageof 1